This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Analog Devices And MIT Collaborate To Develop Medical Technologies For Patient Monitoring Devices

Analog Devices, Inc. (NYSE: ADI), a global leader in high-performance semiconductors for signal-processing applications and long-time supplier to the medical equipment industry, today announced a collaboration with the Massachusetts Institute of Technology (MIT) to research and develop technologies for next-generation patient monitoring devices. Through MIT’s new Medical Electronic Device Realization Center (MEDRC), senior ADI engineers and MIT research scientists will work side by side developing new technologies for portable devices that can check vital signs, such as heart rate, blood pressure, blood oxygenation and respiratory rate, in the comfort of a patient’s home.

“Thanks to modern technology, medical devices that once were found only in a hospital or doctor’s office are finding their way in different form factors into our homes,” said Patrick O’Doherty, vice president, Healthcare Group, Analog Devices. “Analog Devices is excited to work with MIT on researching new technologies that further the movement of bringing technology into the home and enable medical devices companies to design the next generation of portable, affordable and reliable patient monitoring systems.”

According to the Centers for Medicare and Medicaid Services, in 2009 the United States spent more than 50 percent of the $2.5 trillion in healthcare expenditures on hospital care and physician clinical services. Patient monitoring devices employed in the home can significantly reduce these costs by shortening the length of hospital stays and reducing the number of doctor visits required for routine monitoring.

“Moving patient care into the home marks a radical change in how healthcare is delivered and innovative medical devices are essential to making this important shift possible,” said Dr. Charles Sodini, MIT professor and co-founder of the MEDRC. “The goal of our research with ADI is to provide medical device companies with the technology necessary to create continuous vital signs monitoring systems that improve the lives of patients throughout the world.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs